During the past decade, Chesapeake Research Group conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 16 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 9 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chesapeake Research Group" #1 sponsor was "Iroko Pharmaceuticals, LLC" with 3 trials, followed by "Vertex Pharmaceuticals Incorporated" with 3 trials sponsored, "AFT Pharmaceuticals, Ltd." with 2 trials sponsored, "Baudax Bio" with 2 trials sponsored and "Centrexion Therapeutics" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chesapeake Research Group" #1 collaborator was "Premier Research Group plc" with 2 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Chesapeake Research Group" are "Acute Pain" (4 trials), "Other Acute Postoperative Pain" (3 trials), "Pain, Postoperative" (3 trials), "Postoperative Pain" (3 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Chesapeake Research Group" in a lesser frequency.

Most popular intervention types in "Chesapeake Research Group" are "Drug" (33 trials), "Device" (3 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "CNTX-4975" (2 trials), "Celecoxib" (2 trials), "HB/APAP" (2 trials) and "Indomethacin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chesapeake Research Group" are 37 trials for "All" genders.

Currently, there are NaN active trials in "Chesapeake Research Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Chesapeake Research Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Chesapeake Research Group, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".